Paper39759152
Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound.
Tian H and 5 others. Front Oncol, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound. Papers, record 39759152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39759152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37804423 | Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma? | Abdom Radiol (NY) | 2024 | https://conductscience.org/library/papers/37804423 | PubMed |
| 2 | 35397928 | Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics. | Ultrasound Med Biol | 2022 | https://conductscience.org/library/papers/35397928 | PubMed |
| 3 | 33510294 | The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. | Sci Rep | 2021 | https://conductscience.org/library/papers/33510294 | PubMed |
| 4 | 33205035 | New insights into the pathophysiology and clinical care of rare primary liver cancers. | JHEP Rep | 2021 | https://conductscience.org/library/papers/33205035 | PubMed |
| 5 | 30803409 | Predictive Value of Contrast-enhanced Ultrasound for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection. | Ultrason Imaging | 2019 | https://conductscience.org/library/papers/30803409 | PubMed |
| 6 | 35705829 | Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma. | Eur Radiol | 2022 | https://conductscience.org/library/papers/35705829 | PubMed |
| 7 | 34503212 | Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503212 | PubMed |
| 8 | 31887773 | A Review on the Update of Combined Hepatocellular Cholangiocarcinoma. | Semin Liver Dis | 2020 | https://conductscience.org/library/papers/31887773 | PubMed |
| 9 | 35646649 | The Roles of Diffusion Kurtosis Imaging and Intravoxel Incoherent Motion Diffusion-Weighted Imaging Parameters in Preoperative Evaluation of Pathological Grades and Microvascular Invasion in Hepatocellular Carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/35646649 | PubMed |
| 10 | 32385649 | Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? | Eur Radiol | 2020 | https://conductscience.org/library/papers/32385649 | PubMed |
| 11 | 33751300 | Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling Protocol. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/33751300 | PubMed |
| 12 | 34123861 | Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion. | Front Oncol | 2021 | https://conductscience.org/library/papers/34123861 | PubMed |
| 13 | 35526789 | Methodological considerations regarding a gene signature to predict microvascular invasion in hepatocellular carcinoma. | J Hepatol | 2022 | https://conductscience.org/library/papers/35526789 | PubMed |
| 14 | 34485317 | Contrast-Enhanced Ultrasound Findings of Hepatocellular Carcinoma With Neuroendocrine Carcinoma: A Case Report. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34485317 | PubMed |
| 15 | 30788629 | Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. | Ann Surg Oncol | 2019 | https://conductscience.org/library/papers/30788629 | PubMed |
| 16 | 33816254 | Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection. | Front Oncol | 2021 | https://conductscience.org/library/papers/33816254 | PubMed |
| 17 | 37121101 | Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data. | Eur J Radiol | 2023 | https://conductscience.org/library/papers/37121101 | PubMed |
| 18 | 36567144 | Contrast-Enhanced Ultrasound with Deep Learning with Attention Mechanisms for Predicting Microvascular Invasion in Single Hepatocellular Carcinoma. | Acad Radiol | 2023 | https://conductscience.org/library/papers/36567144 | PubMed |
| 19 | 28249328 | Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR). | Ultraschall Med | 2017 | https://conductscience.org/library/papers/28249328 | PubMed |
| 20 | 29312973 | Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. | Hepatobiliary Surg Nutr | 2017 | https://conductscience.org/library/papers/29312973 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42226136 | Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42226136 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39759152
GET https://conductscience.org/api/papers/v1/39759152/references?page=2